Skip to main content

UCI MIND Annual Report 2020: Excellence through Adversity

By Commentary, COVID-19, In the News
UCI MIND Annual Report 2020: Excellence through Adversity Dear Friend of UCI MIND, The COVID-19 pandemic has impacted every facet of life, especially for families enduring Alzheimer’s disease and related dementias. In 2020 alone, deaths due to Alzheimer’s increased 16% in the United States. Caregivers were forced to adapt how they manage care and cope with burden, while many endured painful separation from loved ones. Researchers faced delays and challenges in continuing our work. Yet, the past year has further ignited in us an urgency to discover solutions for Alzheimer’s disease and related dementias and improve the lives of those…
Read More

Minorities Receive Less Timely Dementia Diagnoses Than Whites

By Carousel Slider, Commentary, In the News
CHINNAPONG/GETTY IMAGES An accompanying editorial in JAMA Neurology noted that the study apparently is the first to focus on disparities related to “time to diagnosis and comprehensiveness of evaluation” of dementia. Claudia Kawas, M.D., a , geriatric neurologist and researcher at the University of California, Irvine, and other authors of the editorial … point to the need for more diversity in dementia research — particularly as the aging U.S. population grows more diverse.
Read More

Join us for UCI Giving Day on Wednesday, April 28!

By Commentary, Community Events
COVID-19 has introduced tremendous uncertainty into our lives. It has made life challenging for many, none more than families facing Alzheimer’s disease and related dementias. Yet, one certainty remains – brain diseases will devastate our increasingly older population…unless researchers find solutions. UCI MIND remains focused on these efforts. To support the scientists, students, and programs across our great university, donate to dementia research on #UCIGivingDay coming up on Wednesday, April 28th. Help us rise to the challenge and unlock a $2,500 gift in support of Alzheimer's research from Belmont Village by being one of the first 50 donors to UCI…
Read More

Training for Professionals serving Individuals with Intellectual and Developmental Disabilities

By Commentary, Community Events
Our community partners, Alzheimer’s Orange County, the UCI Down Syndrome Program at UCI MIND, the Regional Center of Orange County and the Down Syndrome Association of Orange County, have provided an ongoing education and support program to individuals and families living with Down syndrome and Alzheimer’s disease. To learn more, visit: https://www.alzoc.org/resources/idd/ There will be a three-part training series offered in May for those working in group homes, day programs, & other agencies. The flyer is listed below and the PDF is accessible here >
Read More

Sex differences in hallmarks of Alzheimer’s disease: new study finds faster tau accumulation in female brains

By Commentary, Community Events, In the News
Contributed by Ashley A. Keiser, PhD A new study from researchers in Sweden published in Brain finds faster accumulation of a major hallmark of Alzheimer’s disease, neurofibrillary protein aggregates containing tau in female, compared with male brains. Researchers also found greater memory impairments in women with Alzheimer’s disease. Sex differences in Alzheimer’s disease risk have been extensively reported. Particularly, women exhibit greater cognitive impairment and the rate of acceleration of impairment is observed to exceed men. Women are also twice as likely to be diagnosed with Alzheimer’s disease. Although previous cross-sectional studies that capture a single data point in time…
Read More

UCI MIND faculty member Dr. Tahseen Mozaffar awarded $4.2M grant to study rare muscle disorder affecting aging Americans

By Carousel Slider, Commentary, In the News
UCI School of Medicine Tahseen Mozaffar, MD, a professor of neurology and director of the Division of Neuromuscular Disorders and the UCI-MDA ALS and Neuromuscular Center at UCI's School of Medicine will lead a study on sporadic inclusion body myositis (sIBM), which affects aging adults causing asymmetric muscle weakness and severe disability. Currently untreatable, sporadic inclusion body myositis (sIBM) causes muscle weakness and severe disability Irvine, CA – April 6, 2021 – The National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded UCI a 5-year, $4.2 million grant to study sporadic inclusion body myositis (sIBM), which affects aging adults…
Read More